Analysis - Page 1
Stay up to date with the latest Analysis updates from the global pharmaceutical industryLatest Analysis Update
The outdoor lab: growing pharmaceuticals in plants Growing medicines in open fields could slash the cost of drug production and make life-saving vaccines easily available to people in the developing world. But current regulations mean it...
Trialling the first ever HIV vaccine In October 2012, Canadian scientists announced that they may have discovered the first and only preventative HIV vaccine that has shown no adverse effects in Phase I human clinical trials....
Saving Syria’s drug supply with Medecins Sans Frontieres The situation in Syria has gone from bad to worse and is only set to deteriorate further. So how are the millions of displaced refugees getting access to essential medical care and supplies?...
Virtualising the pharma chain – why the cloud is the only way forward As pharmaceutical supply networks become more and more complex, involving collaboration between hundreds, or even thousands, of entities around the world, traditional supply chain management...
Will Obama live up to his promises on AIDS? President Obama has been carried back into the Oval Office on another wave of optimism, but is there reason to doubt his promise to tackle the global AIDS epidemic? Chris Lo checks out...
In short supply: tackling the drug shortage crisis As patents expire, big pharmaceutical firms are lacking economic impetus to provide a constant supply of drugs to the market. But, a lower margin in generic manufacturing also means the...
Pursuing an Alzheimer’s breakthrough Alzheimer's disease affects at least 18 million people worldwide, nevertheless a cure continues to evade scientists, with recent high-profile trial failures adding to growing concern. But...
Pharmaceutical science - catching up with Armstrong’s doping Peloton The exposure of Lance Armstrong's doping campaign has rocked not only the world of cycling, but also anyone who had any faith in anti-doping pharmacology and detection. Liam Stoker...
US elections 2012: a crossroad for stem cell research? Stem cell research has always been a controversial practice in the US. Will the upcoming election prompt any change in the field's fortunes? Chris Lo checks out the opposing stem cell positions...
Tackling pharmaceutical counterfeits: beyond packaging With a large proportion of the developing world unable to afford genuine medication, black market counterfeits are the only option for many. As a result, a shocking number of medicines on...
Twitter
Facebook